Biofrontera Inc. Faces Delisting Concerns
Ticker: BFRIW · Form: 8-K · Filed: May 23, 2025 · CIK: 1858685
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: BFRI
TL;DR
BFRI might get delisted - stock could tank.
AI Summary
Biofrontera Inc. filed an 8-K on May 23, 2025, reporting a notice of delisting or failure to meet continued listing standards as of May 21, 2025. The company, incorporated in Delaware with its principal executive offices in Woburn, Massachusetts, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing indicates potential issues with Biofrontera Inc.'s ability to remain listed on its current exchange, which could significantly impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading and investor confidence.
Key Players & Entities
- Biofrontera Inc. (company) — Registrant
- May 21, 2025 (date) — Earliest event reported
- May 23, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Woburn, Massachusetts (location) — Principal executive offices
- 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific listing rule or standard has Biofrontera Inc. failed to meet?
The filing does not specify the exact rule or standard that Biofrontera Inc. has failed to meet, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 21, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on May 23, 2025.
In which state is Biofrontera Inc. incorporated?
Biofrontera Inc. is incorporated in Delaware.
What is the business address of Biofrontera Inc.?
The business address of Biofrontera Inc. is 120 Presidential Way, Suite 330, Woburn, Massachusetts 01801.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding Biofrontera Inc. (BFRIW).